Food Obstruction Action Plan update

Jan 2021 - We need you to answer our survey to help us develop an action plan for when food gets stuck in the oesophagus. Help us get it right! Read more

EUREOS & TIGERS 2nd Joint Webinar

Following November's success, EUREOS and TIGERS are hosting another interactive webinar on March 3rd. Talks include dietary treatments in EoE and monitoring treatment response. Read more

Eosinophils and COVID Virtual Seminar

Jan 2021 - The International Eosinophil Society (IES) is holding a virtual seminar on 'Eosinophils and COVID'. Talks will include the involvement of eosinophils in viral infections, Covid-19 and eosinophilic diseases, and vaccine hypersensitivity. Read more

US Grants Priority Review for New EoE Treatment

Jan 2021 - The US FDA has granted priority review for Takeda's new budesonide oral suspension for treatment of eosinophilic oesophagitis (EoE). If successful, TAK-721 will be the first EoE treatment to be approved in the US. Read more

Phase 3 trial for Fasenra in EoE begins

Dec 2020 - AstraZeneca has begun its Phase 3 trial evaluating Fasenra in EoE and other eosinophilic diseases. It has also announced a further Phase 3 trial evaluating the drug for EG and EGE. Read more

Screening data from ENIGMA study reveals under-diagnosis of EG and EGE

Nov 2020 - Growing evidence that Eosinophilic Gastritis and Eosinophilic Gastroenteritis are under-diagnosed. 58% of moderate-severely symptomatic patients without diagnoses who entered the ENIGMA study met histologic criteria for EG/EGE Read more

ENIGMA Lirentelimab lower EGID study published

Nov 2020 - Allakos have published the results of the ENIGMA Phase 2 study of Lirentelimab for EG and EGE patients, showing meaningful and statistically significant benefits. The study appears in the October 2020 edition of the NEJM Read more

EUREOS & TIGERS Joint Webinar

Nov 2020 - On November 30th, EUREOS and TIGERS are holding the first joint meeting on Challenges in EoE, a global webinar for HCPs, researchers and industry representatives. Read more

Dupilumab EoE Treatment Phase 3 Trial

Oct 2020 - Dupixent® (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Symptom Read more

USA National Institute of Health Support Research In Covid-19 and Rare Diseases Including Eosinophilic Diseases

May 2020 - USA National Institute of Health Support Research In Covid-19 and Rare Diseases Including Eosinophilic Diseases- Read the full article here Read more

Covid-19 EGID Update from CEGIR

Mar 2020 - Video from CEGIR with an update on Covid-19 and Eosinophilic Diseases Read more

The future may include diagnostic biomarkers for EG Eosinophilic Gastritis

Feb 2020 - Research into blood and tissue markers for EG Eosinophilic Disease study published by CEGIR. Read more

The first EoE licensed drug approved

Oct 2019 - Jorveza - Budesonide in an Orodispersible tablet the only EOE drug approved by European Medical Agency - read the full article Read more

Allakos Announces Multiple Presentations

Oct 2019 - Allakos Announces Multiple Presentations from Its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting. Read more